Adisoft Technologies IPO Live GMP Today

Last GMP recorded

As of 29 Apr 2026, 02:06 pm IST, Adisoft Technologies SME IPO is quoting a grey market premium of +₹22 (+12.8% over the issue price), implying a listing around ₹194 per share.

Current GMP
+22
(+12.8%)
▲ ₹6 vs yesterday
Updated Apr 29, 2026 02:06 pm
Issue Price
₹172
Band: ₹163 - ₹172
Expected Listing
₹194
Based on current GMP
Est. Gain / Lot
+₹35,200
+12.8% on listing
₹2,75,200 → ₹3,10,400 (1600 sh)
IPO Details
StatusListed
TypeSME
Open DateApr 23, 2026
Close DateApr 27, 2026
Listing DateApr 30, 2026
Lot Size1600 shares
Issue Size₹74.00 Cr
GMP Trend
GMP History
Date GMP (Rs) Change GMP % Est. Listing
Apr 29, 2026 02:06 pm +22 ▲ 6 +12.8% ₹194
Apr 28, 2026 06:12 pm +16 ▼ 2 +9.3% ₹188
Apr 27, 2026 07:54 pm +18 ▲ 3 +10.5% ₹190
Apr 27, 2026 03:35 pm +15 ▼ 2 +8.7% ₹187
Apr 27, 2026 07:55 am +17 ▲ 7 +9.9% ₹189
Apr 23, 2026 07:23 am +10 ▲ 10 +5.8% ₹182
Apr 21, 2026 07:08 am +0 +0.0% ₹172

Adisoft Technologies IPO GMP — Detailed Analysis

What Adisoft Technologies GMP Tells Us Today

The current Grey Market Premium for Adisoft Technologies IPO is Rs 22 (12.8% over the issue price). Based on this GMP, the implied listing price hovers around Rs 194 per share. Across the 7 GMP records captured for this issue, the trend has been rising by Rs 22 — a useful directional signal for gauging investor sentiment as the listing date approaches.

Adisoft Technologies IPO is expected to list on April 30, 2026.

Adisoft Technologies IPO GMP — FAQs

The current GMP for Adisoft Technologies IPO is Rs 22 (12.8%), indicating an estimated listing price of Rs 194.

Adisoft Technologies IPO is expected to list on April 30, 2026.

The price band for Adisoft Technologies IPO is Rs 163 to Rs 172 per share.

New to grey market data? The hub covers how to read a GMP trend and how SME GMP compares with actual listing performance, and our explainer goes deeper: What is IPO GMP?

GMP (Grey Market Premium) is based on unofficial market activity and does not guarantee listing price. IPO investments are subject to market risk. Please read the offer document before investing.
GMP Update